2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
7
Polycystic Ovary Syndrome
6
Insulin Resistance
2
Hyperandrogenism
2
Primary Dysautonomias
1
Metabolic Syndrome
1
Hot Flashes
1
Hirsutism
1
Erectile Dysfunction
1
Dermatitis, Seborrheic
1
Alopecia
1
Adenocarcinoma
1
Acne Vulgaris
1
Interventions
Sildenafil Citrate
9
Tadalafil
4
Surveys and Questionnaires
2
Pentoxifylline
2
Alprostadil
2
udenafil
1
trametinib
1
sotorasib
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
mirabegron
1
methyl 3-mercaptopropionimidate
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
brigatinib
1
bicalutamide
1
alpha-Tocopherol
1
alectinib
1
Yoga
1
Vitamin E
1
Tamoxifen
1
Tacrolimus
1
Tablets
1
Surgical Instruments
1
Saline Solution
1
Restraint, Physical
1
Psychiatric Rehabilitation
1
Preservation, Biological
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Erectile Dysfunction
×
Cyproterone Acetate
×
Clear all
NCT00919022
2012-11-01
ANES
Bayer
Terminated
194 enrolled